Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
/in Dendritic Cells, International PublicationsLocal control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
/in Breast Cancer, Hyperthermia, International PublicationsAdvances in the understanding of cancer immunotherapy
/in Dendritic Cells, International PublicationsVaccine immunotherapy in lung cancer: Clinical experience and future directions
/in International Publications, NSCLC, SCLCHyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
/in Hyperthermia, International PublicationsIPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
/in International Publications, Newcastle Disease VirusPrecision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
/in Dendritic Cells, International PublicationsHuman renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
/in Hypernephroma, International Publications, Newcastle Disease VirusHyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
/in Breast Cancer, Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer